Javascript seems to be disabled. This will break some core site features. Please enable javascript or revisit this site from another device.
8-10 June
Below you’ll find all the accepted abstracts for the conference. These will all be presented either as an oral presentation during one of our two free communication sessions or as a poster. If there is no link for the abstract, the author does not approve of publishing.
Incidence and predictors of severe altitude illness symptoms in Mt. Kilimanjaro hikers; a prospective cohort study
Patrick Soentjens
Fluid therapy for severe malaria
Laura Kalkman
Real world evidence data on rabies prophylaxis in Serbia
Pavle Banović
Progress of Clinical Development of a Live-Attenuated Single Shot Chikungunya Vaccine Candidate
Vera Buerger
Pregnancy outcomes in women exposed to atovaquone-proguanil in first-trimester pregnancy
Kirsten Macgregor
The enigma of recurrence: post-tuberculosis treatment paradoxical reactions
Sabine Hermans
Infection Tracking in Travellers Using A Mobile App (ITIT) : The Pilot Study
Nadja Hedrich
Efficacy and Safety of Takeda’s Tetravalent Dengue Vaccine Candidate (TAK-003) After 4.5 Years of Follow-Up
Vianney Tricou
Persistence of immunogenicity of a purified inactivated Zika virus vaccine candidate in healthy adults: two years follow-up compared with natural infection
Camilo Acosta-Rodriguez
Scoring systems for prediction of malaria and dengue fever in returning travelers
Klara Sondén
In the order they are displayed at the conference.
Stability of cholera vaccine CVD 103-HgR under varying environmental conditions
Paul Duffin
Viability of cholera vaccine CVD 103-HgR in drinking waters from the US and Europe
Paul Duffin
Modeling the kinetics and durability of the humoral response to a chikungunya virus-like particle vaccine
Steven Stoddard
Cholera in Travellers: Improving Vaccination Guidance in Europe
Ranjini Prithviraj
Nordic travelers’ knowledge about mode-of-transmission of malaria and vaccine preventable diseases
Carsten Schade Larsen
A review of Yellow Fever Vaccination Centre activity in England, Wales, and Northern Ireland during the COVID-19 pandemic
Rachael Fletcher
Co-administration of a tetravalent dengue vaccine (TAK-003) with hepatitis A vaccine
Sanja Mandaric
Immunogenicity and Duration of Protection After Yellow Fever Vaccine in People Living with HIV: A Systematic Review
Charlotte Martin
Tetravalent Dengue Vaccine (TAK-003) Development Program: A Bird’s Eye View
Eckhardt Petri
Proposing a semiquantitative tool for exposure to Trypanosoma cruzi: the Chagas Exposure Score (CES)
Burkhard Rieke
A Review of Enquiries Received by a National COVID-19 Travel Health Advice Service
Fatima Abba
Epidemiology and clinical findings of influenza in international travellers
Fabian Shijaku
VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment
Dorothea Pana Zoi
Primary prevention of mosquito borne disease in international travellers: Qualitative exploration of factors that influence the use of personal protection measures.
Lonneke De Graaf-Oosterom
A comparison of enquiries to a national telephone advice line by health professionals, between 2016 and 2019 relating to cruise ship travel.
Alexandra Stillwell
Haematological changes in Schistosoma haematobium infected returned travellers
Jenny Schnyder
Mosquito on Board: Do Exotic Mosquitoes Stow-away on Aircraft Entering Europe?
Nadja Hedrich
Five accelerated schedules for the TBE vaccine FSME- Immun® in last-minute travellers: an open-label, single-centre, randomized controlled trial.
Nicole Berens-Riha
Spotted fever group rickettsiae (SFG) in Borrelia burgdorferi s.l. seropositive patients with or without Lyme disease in Switzerland
Patricia Schlagenhauf
Understanding how enquiries made by doctors to the UK’s National Travel Advice Line differ to those made by any healthcare professional.
Kirsten Macgregor